scholarly journals Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics

2019 ◽  
Vol 12 (3) ◽  
pp. 189-195 ◽  
Author(s):  
Lance R. McMahon
2012 ◽  
Vol 24 (4) ◽  
pp. 609-628 ◽  
Author(s):  
M. Manning ◽  
A. Misicka ◽  
A. Olma ◽  
K. Bankowski ◽  
S. Stoev ◽  
...  

2020 ◽  
Vol 39 (1) ◽  
pp. 149-160
Author(s):  
Teresa de Rojas ◽  
Anouk Neven ◽  
Alexander J. Towbin ◽  
Fernando Carceller ◽  
Francisco Bautista ◽  
...  

2012 ◽  
Vol 46 (5) ◽  
pp. i
Author(s):  
Richard N. Fedorak

Author(s):  
Eman M. El-labbad ◽  
Xingyue Ji ◽  
Khaled A.M. Abouzid ◽  
Binghe Wang

SO2 is emerging as a possible endogenous signaling molecule in mammals. In addition, SO2 has also shown pharmacological effects, presenting SO2 as a promising potential therapeutic agent. The past decade has witnessed steady advances in the development of small molecule-based SO2 prodrugs/donors with varied release mechanisms. Herein, we summarize various strategies employed for SO2 prodrug design. The remaining challenges and issues will also be discussed.


1984 ◽  
Vol 48 (8) ◽  
pp. 448-452
Author(s):  
LA Tedesco ◽  
JE Albino ◽  
WM Feagans ◽  
RS Mackenzie

2001 ◽  
Vol 11 (2) ◽  
pp. 9-11
Author(s):  
Madalena Walsh ◽  
Nan Bernstein Ratner
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document